For gastrointestinal use, it is commonly discussed for gut irritation, gastritis-type symptoms, reflux-type irritation, inflammatory gut symptoms, and mucosal support
NHS B12 therapy is evidence-based for documented deficiency, using hydroxocobalamin 1mg intramuscularly with standardised protocols
In the context of long COVID, Ta1 addresses the immune exhaustion and dysregulation that characterizes the condition, helping to restore appropriate T cell function, support viral clearance, and modulate the inflammatory cytokine environment
One regulatory note worth holding alongside his framing: the FDA placed several of the peptides he discusses (including BPC-157, CJC-1295, and Ipamorelin) onto a Category 2 list in 2023, citing a lack of safety data rather than reported harms